[1]
Eandi, M. 2011. Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection. Farmeconomia. Health economics and therapeutic pathways. 12, 2 (Jun. 2011), 61–76. DOI:https://doi.org/10.7175/fe.v12i2.72.